Sascha Goonewardena
Manage Your Profile
About
I am an Associate Professor of Medicine, the Associate Director of the Vascular Defense and Discovery Laboratory, and the inaugural Wolfe Immunocardiology Scholar in the Division of Cardiovascular Medicine at the University of Michigan. My research focuses on translational studies and the basic mechanisms of innate immune responses, including how innate immune cells respond to endogenous stress, how they modulate their responses in a context-dependent manner, and the molecular interactions between immune and non-immune cells during the initiation of inflammatory responses. I completed a postdoctoral fellowship at the University of Chicago, using murine models and systems biology approaches to elucidate the innate immune mechanisms underlying heart failure. As an NIH T32 postdoctoral fellow and during my K08 award (NIH/NHLBI), I employed multidimensional cytometry and bioinformatics (including transcriptomics, metabolomics, and proteomics) to investigate innate immune mechanisms behind chronic inflammatory diseases. Over the past several years, I have used cellular, molecular, and machine learning techniques to understand the immune mechanisms driving cardiometabolic disease. My lab has built on these concepts and technologies, utilizing RNA-seq, various proteomic platforms, flow/mass cytometry, and bioinformatics to study how immune dysfunction accelerates thrombotic and cardiovascular diseases. I also serve as the Principal Investigator on a CSR&D Merit award, an investigator-initiated industry contract in which I use a microfluidic proteomic platform I developed to examine circulating immune phenotypes in patients treated with a PCSK9 inhibitor. Additionally, I am a reviewer for high-impact medical journals and an associate editor of the Journal of Clinical Lipidology and Cardiovascular Drugs and Therapeutics, with over 70 manuscripts published.
Qualifications
-
ResidencyUniversity of Chicago Hospital, Internal Medicine, Chicago IL, United States
2004 - 2026
-
Postdoctoral Research FellowUniversity of Michigan–Ann Arbor, Immunology and Nanotechnology, Ann Arbor, United States
2009 - 2011
-
FellowshipUniversity of Michigan–Ann Arbor, Cardiovascular Medicine, Ann Arbor, United States
2007 - 2009
-
Postdoctoral Research FellowUniversity of Chicago Medical Center, Genomics/systems biology, Chicago, United States
2006 - 2007
-
InternshipUniversity of Chicago Hospitals, Internal Medicine, Chicago, IL, United States
2003 - 2004
Center Memberships
-
Center MemberTaubman Institute
-
Center MemberSamuel and Jean Frankel Cardiovascular Center
Research Overview
Innate immunity and macrophage biolog
Heart Failure and Atherosclerotic Cardiovascular Disease
Vascular Biology
Recent Publications
-
Rosenson RS, Goonewardena SN. Lancet, 2026 Sep 5; 408 (10558): 868 - 869.Journal ArticleDeep and durable lipoprotein(a) lowering: Kylo-11 advances RNA interference therapeutics
DOI:10.1016/S0140-6736(26)01639-9 PMID: 42664980 -
Sriram R, Wood IN, Shahrabani E, Goonewardena S, Yao S, Gundl L, Loring Z, Murthy VL. Heart Rhythm O2, 2026 Sep 21; 7 (9): s58Journal ArticleID: 4567170 SCALING LAWS IN ECG FOUNDATION MODELS: PRE-TRAINING DATA VOLUME DRIVES PERFORMANCE GAINS ACROSS RHYTHM, FORM, DIAGNOSIS, AND STRUCTURAL HEART DISEASE TASKS
DOI:10.1016/j.hroo.2026.08.098 -
Rosenson RS, Goonewardena SN. Jacc Cardiovascular Imaging, 2026 Sep 1; 19 (9): 1120 - 1121.Journal ArticleLipoprotein(a) and Coronary Atherosclerosis: Does Risk Travel Through Plaque Burden, Plaque Vulnerability, or Both?
DOI:10.1016/j.jcmg.2026.07.009 PMID: 42710998 -
GOONEWARDENA SN, AZUBUIKE-OSU SO. Journal of Cardiac Failure, 2026 Aug 1; 32 (8): 1373 - 1375.Journal ArticleFrom Prognosis to Therapy: suPAR and the Inflammatory Frontier in Heart Failure
DOI:10.1016/j.cardfail.2026.05.006 PMID: 42263932 -
Thomas P, Nielsen S, Goonewardena S, Nordestgaard B, Rosenson R, Kamstrup P. Atherosclerosis, 2026 Sep 10; 419: 121697Journal ArticleLIPOPROTEIN(A) LOWERING AND RISK OF CARDIOVASCULAR DISEASE IN PRIMARY AND SECONDARY PREVENTION
DOI:10.1016/j.atherosclerosis.2026.121697 -
Zhang L, Omarov M, Xu LL, Das B, Luo H, Hauck SM, Petrera A, Yu Z, Goonewardena SN, Zeggini E, Peters A, Dichgans M, Murthy VL, Thorand B, Georgakis MK. Cardiovascular Research, 2026 Aug 1; 122 (12): 1589 - 1608.Journal ArticleProteomic signatures as biomarkers of atherosclerosis burden
DOI:10.1093/cvr/cvag140 PMID: 42367007 -
Sriram R, Nenadic I, Shahrabani E, Goonewardena SN, Yao S, Farrell B, Loring Z, Murthy VL. 2026 Jul 17;PreprintScaling ECG Foundation Models and Identifying a Threshold for Effective Representation Learning.
DOI:10.64898/2026.07.15.26358182 PMID: 42528512 -
Goonewardena SN, Rosenson RS. Journal of the American Society of Nephrology, 2026 Jul 1; 37 (7): 1376 - 1378.Journal ArticleInclisiran in CKD: A Therapeutic Answer to a Persistent Treatment Gap
DOI:10.1681/ASN.0000001127 PMID: 42160189
Featured News & Stories